G.-S. Jiao et al. / Tetrahedron 59 (2003) 3109–3116
3113
7.56–7.27 (m, 16H), 7.10 (d, J¼8.0 Hz, 2H), 6.02 (s, 2H),
4.33 (q, J¼7.2 Hz, 4H), 1.83 (br s, 12H), 1.36 (t, J¼7.2 Hz,
6 H); HR-MS (MALDI) for C58H51N4O6 (MþHþ) calcd
899.3809, found 899.3825.
121.42, 115.68, 110.30, 63.27, 50.62, 17.91, 14.59; HR-MS
(MALDI) for C24H21N2O2S (MþHþ) calcd 401.1324,
found 401.1264.
1
Compound 8a.21 86%. H NMR (300 MHz, DMSO-d6) d
Compound 3a. 91%. 1H NMR (300 MHz, CDCl3) d 7.37 (t,
J¼7.2 Hz, 2H), 7.31 (d, J¼7.2 Hz, 2H), 7.19 (t, J¼7.2 Hz,
2H), 6.91 (d, J¼7.2 Hz, 2H), 5.87 (s, 2H), 4.76 (br s, 4H),
4.26 (q, J¼7.2 Hz, 4H), 1.81 (br s, 12H), 1.29 (t, J¼7.2 Hz,
6H); HR-MS (MALDI) for C34H37N2O6 (MþHþ) calcd
569.2652, found 569.2627.
8.52 (d, J¼7.8 Hz, 1H), 8.30 (d, J¼7.8 Hz, 1H), 7.90 (t,
J¼7.8 Hz, 1H), 7.82 (t, J¼7.8 Hz, 1H), 5.91 (s, 2H), 4.24 (q,
J¼7.2 Hz, 2H), 3.23 (s, 3H), 1.25 (t, J¼7.2 Hz, 3H); 13C
NMR (75.4 MHz, DMSO-d6) d 180.31, 166.00, 141.78,
130.38, 129.29, 129.04, 125.62, 117.34, 63.30, 50.45, 17.84,
14.60.
4.1.4. Preparation of compound 7b. Carbazole (184 mg,
1.1 mmol), 5-bromo-2-methylbenzothiazole (228 mg, 1.00
mmol), and sodium tert-butoxide (134 mg, 1.40 mmol)
were placed in a Schlenk tube. Tris(dibenzylideneacetone)-
dipalladium (23 mg, 0.02 mmol) and 2-(di-t-butylphosphino)-
biphenyl (12 mg, 0.04 mmol) were weighed in glove box,
the tube was removed from the box, then toluene (2 mL)
was added. The mixture was heated at 1008C for 2 h. After
cooling to room temperature, the reaction mixture was
diluted with ether and filtered through a pad of celite. The
residue after removal of solvent was purified by flash
column chromatography using 20% EtOAc/hexane to give
the product as a white solid (256 mg, 82%). 1H NMR
(300 MHz, CDCl3) d 8.23–8.19 (m, 3H), 8.02 (d, J¼8.7 Hz,
1H), 7.58 (dd, J¼8.1, 1.8 Hz, 1H), 7.51–7.42 (m, 4H), 7.35
(td, J¼8.1, 1.8 Hz, 2H), 2.93 (s, 3H); 13C NMR (75.4 MHz,
CDCl3) d 169.23, 154.83, 141.29, 136.23, 126.36, 126.08,
124.18, 123.74, 122.80, 121.19, 120.67, 120.41, 110.02,
20.62; HR-MS (ESI) for C20H15N2S (MþHþ) calcd
315.0956, found 315.0926.
Compound 8c. 68%. 1H NMR (300 MHz, DMSO-d6) d 8.66
(dd, J¼8.7, 1.8 Hz, 1H), 8.36 (d, J¼1.8 Hz, 1H), 7.82 (dd,
J¼8.7, 1.8 Hz, 1H), 7.24 (dd, J¼7.2, 1.8 Hz, 2H), 7.07–
6.97 (m, 4H), 6.39 (dd, J¼7.2, 1.8 Hz, 2H), 5.84 (s, 2H),
4.17 (q, J¼7.2 Hz, 2H), 3.25 (s, 3H), 1.18 (t, J¼7.2 Hz, 3H);
13C NMR (75.4 MHz, DMSO-d6) d 180.89, 165.19, 143.14,
142.76, 142.59, 128.63, 127.53, 127.35, 127.12, 124.01,
123.80, 122.27, 118.30, 115.98, 62.53, 49.87, 17.16, 13.84;
HR-MS (MALDI) for C24H21N2O2S2 (MþHþ) calcd
433.1045, found 433.1066.
Compound 8d. 70%. 1H NMR (300 MHz, DMSO-d6) d 8.75
(d, J¼8.7 Hz, 1H), 8.62 (d, J¼1.8 Hz, 1H), 7.90 (dd, J¼8.7,
1.8 Hz, 1H), 6.84–6.64 (m, 6H), 5.87 (dd, J¼7.5, 1.5 Hz,
2H), 5.86 (s, 2H), 4.20 (q, J¼7.2 Hz, 2H), 3.26 (s, 3H), 1.19
(t, J¼7.2 Hz, 3H); 13C NMR (75.4 MHz, DMSO-d6) d
181.09, 164.87, 143.22, 143.12, 139.69, 133.25, 130.60,
128.64, 127.79, 123.55, 122.07, 119.62, 115.47, 113.33,
62.36, 49.82, 17.11, 13.67; HR-MS (MALDI) for
C24H21N2O3S (MþHþ) calcd 417.1273, found 417.1276.
Compound 7c. 76%. 1H NMR (300 MHz, CDCl3) d 8.31 (s,
1H), 8.02 (d, J¼5.7 Hz, 1H), 7.37 (dd, J¼8.4, 1.8 Hz, 1H),
7.07–7.04 (m, 2H), 6.86–6.82 (m, 4H), 6.29–6.25 (m, 2H),
2.90 (s, 3H); 13C NMR (75.4 MHz, CDCl3) d 169.09, 155.52,
144.51, 139.44, 135.71, 127.42, 127.14, 127.08, 124.97,
123.80, 122.94, 120.76, 116.60, 20.59; HR-MS (ESI) for
C20H15N2S2 (MþHþ) calcd 347.0671, found 347.0653.
Compound 7d. 90%. 1H NMR (300 MHz, CDCl3) d 8.04 (d,
J¼8.4 Hz, 1H), 7.98 (d, J¼1.8 Hz, 1H), 7.34 (dd, J¼8.4,
1.8 Hz, 1H), 6.75–6.56 (m, 6H), 5.96 (dd, J¼8.4, 1.5 Hz,
1H), 2.90 (s, 3H); 13C NMR (75.4 MHz, CDCl3) d 168.95,
155.77, 144.25, 137.40, 136.09, 134.68, 127.26, 125.30,
124.11, 123.47, 121.70, 115.73, 113.63, 20.45; HR-MS
(ESI) for C20H15N2OS (MþHþ) calcd 331.0899, found
331.0867.
4.1.6. Preparation of squaraine 4b. Compound 8b
(100 mg, 0.21 mmol), quinoline (27 mg, 0.21 mmol), and
squaric acid (12 mg, 0.10 mmol) were placed in a round-
bottom flask. A mixture of n-BuOH/toluene (15 mL, 1:1
v/v) was added. The mixture was refluxed for 12 h while
the water formed was azeotropically removed by using a
Dean–Stark trap. After cooling to room temperature, the
reaction mixture was filtered to give a dark-green solid,
which was further washed with ether 3£(81 mg, 83%). A
sample for analysis was obtained by purification through
flash column chromatography using 40% EtOAc/CH2Cl2.
1H NMR (300 MHz, CDCl3) d 8.17 (d, J¼7.8 Hz, 4H), 7.75
(d, J¼8.1 Hz, 2H), 7.48–7.21 (m, 16H), 5.88 (s, 2H), 4.78
(s, 4H), 4.29 (q, J¼7.2 Hz, 4H), 1.32 (t, J¼7.2 Hz, 6H); HR-
MS (MALDI) for C52H39N4O6S2 (MþHþ) calcd 879.2311,
found 879.2334.
4.1.5. Preparation of compound 8b. Compound 7b
(250 mg, 0.800 mmol) and ethyl bromoacetate (160 mg,
0.960 mmol) were weighed into a sealed tube. The mixture
was heated at 808C for 18 h. After cooling to room
temperature, the reaction mixture was poured into ether
and filtered to give a pale green solid which was washed
with ether 2£(322 mg, 84%). 1H NMR (300 MHz, DMSO-
d6) d 8.76 (s, 1H), 8.74 (d, J¼6.9 Hz, 1H), 8.31 (d, J¼
7.5 Hz, 2H), 8.13 (d, J¼7.2 Hz, 1H), 7.48 (d, J¼3.9 Hz,
4H), 7.39–7.34 (m, 2H), 5.92 (s, 2H), 4.25 (q, J¼7.2 Hz,
2H), 3.29 (s, 3H), 1.25 (t, J¼7.2 Hz, 3H); 13C NMR
(75.4 MHz, DMSO-d6) d 181.90, 166.07, 143.18, 140.49,
138.86, 127.88, 127.58, 127.31, 127.22, 123.80, 121.58,
Compound 4a. 96%. 1H NMR (300 MHz, CDCl3) d 7.55 (d,
J¼7.5 Hz, 2H), 7.36 (t, J¼7.5 Hz, 2H), 7.23 (t, J¼7.5 Hz,
2H), 7.02 (d, J¼7.5 Hz, 2H), 5.81 (s, 2H), 4.80 (s, 4H), 4.29
(q, J¼7.2 Hz, 4H), 1.32 (t, J¼7.2 Hz, 6H); HR-MS (ESI) for
C28H25N2O6S2 (MþHþ) calcd 549.1154, found 549.1132.
Compound 4c. 80%. 1H NMR (300 MHz, CDCl3) d 7.72 (d,
J¼8.4 Hz, 2H), 7.26 (dd, J¼8.4, 1.8 Hz, 2H), 7.11–7.08 (m,
4H), 7.02 (d, J¼1.8 Hz, 2H), 6.96–6.86 (m, 8H), 6.32 (dd,
J¼8.1, 1.8 Hz, 4H), 5.85 (s, 2H), 4.75 (s, 4H), 4.27 (q,
J¼7.2 Hz, 4H), 1.29 (t, J¼7.2 Hz, 6H); HR-MS (MALDI)
for C52H39N4O6S4 (MþHþ) calcd 943.1753, found
943.1709.